Company profile · Biotech & medical
Caliway Biopharmaceuticals
康霈生技股份有限公司 · 6919
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Caliway Biopharmaceuticals develops new drugs in the fields of medical aesthetics, chronic inflammatory diseases, and aging.[1]
The company's products under development include small-molecule new drugs such as CBL-514, CBL-514D, and CBA-539 for indications including non-surgical localized fat reduction, Dercum's disease, hyperpigmentation, and anti-aging.[2]
The company has obtained two health food certifications for Golden Formula Gan-Gan-Hao Capsules and Xian-Gan-Hong Capsules.[2]
Caliway Biopharmaceuticals is based in New Taipei City, Taiwan.[1]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$0m | – | – |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$140m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | Caliway Biopharmaceuticals Co., Ltd. |
|---|---|
| Chinese name | 康霈生技股份有限公司 |
| Stock code | 6919 (TWSE) |
| Industry | Biotech & medical |
| Founded | 22 Oct 2012 |
| Listed | 02 Oct 2024 |
| Paid-in capital | NT$779m |
| Chairman | 徐坴暉 |
| President | 凌玉芳 |
| Headquarters | 32F-9, No.99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City, Taiwan |
| Website | https://www.caliwaybiopharma.com |
| Official business description | 專精於醫美與慢性發炎疾病領域的新藥開發 · 健康食品研發 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 康霈生技股份有限公司 · mops · retrieved 04 Nov 2026
- Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list